Vitasora Health Statistics
Total Valuation
Vitasora Health has a market cap or net worth of AUD 48.12 million. The enterprise value is 47.76 million.
Market Cap | 48.12M |
Enterprise Value | 47.76M |
Important Dates
The next estimated earnings date is Tuesday, November 25, 2025.
Earnings Date | Nov 25, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Vitasora Health has 1.72 billion shares outstanding. The number of shares has increased by 37.16% in one year.
Current Share Class | 1.72B |
Shares Outstanding | 1.72B |
Shares Change (YoY) | +37.16% |
Shares Change (QoQ) | +30.19% |
Owned by Insiders (%) | 6.46% |
Owned by Institutions (%) | 9.39% |
Float | 1.37B |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 12.99 |
PB Ratio | 3.28 |
P/TBV Ratio | 29.04 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -4.73 |
EV / Sales | 12.89 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.00.
Current Ratio | 1.46 |
Quick Ratio | 0.59 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -116.79% and return on invested capital (ROIC) is -72.26%.
Return on Equity (ROE) | -116.79% |
Return on Assets (ROA) | -51.35% |
Return on Invested Capital (ROIC) | -72.26% |
Return on Capital Employed (ROCE) | -68.54% |
Revenue Per Employee | 123,506 |
Profits Per Employee | -336,835 |
Employee Count | 30 |
Asset Turnover | 0.30 |
Inventory Turnover | 0.01 |
Taxes
In the past 12 months, Vitasora Health has paid 1,236 in taxes.
Income Tax | 1,236 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.92% in the last 52 weeks. The beta is -0.39, so Vitasora Health's price volatility has been lower than the market average.
Beta (5Y) | -0.39 |
52-Week Price Change | -18.92% |
50-Day Moving Average | 0.03 |
200-Day Moving Average | 0.04 |
Relative Strength Index (RSI) | 52.26 |
Average Volume (20 Days) | 1,808,960 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vitasora Health had revenue of AUD 3.71 million and -10.11 million in losses. Loss per share was -0.01.
Revenue | 3.71M |
Gross Profit | 3.68M |
Operating Income | -10.10M |
Pretax Income | -10.10M |
Net Income | -10.11M |
EBITDA | -10.04M |
EBIT | -10.10M |
Loss Per Share | -0.01 |
Balance Sheet
The company has 419,371 in cash and 57,418 in debt, giving a net cash position of 361,953 or 0.00 per share.
Cash & Cash Equivalents | 419,371 |
Total Debt | 57,418 |
Net Cash | 361,953 |
Net Cash Per Share | 0.00 |
Equity (Book Value) | 14.67M |
Book Value Per Share | 0.01 |
Working Capital | 1.67M |
Cash Flow
Operating Cash Flow | -9.17M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 99.19%, with operating and profit margins of -272.69% and -272.73%.
Gross Margin | 99.19% |
Operating Margin | -272.69% |
Pretax Margin | -272.69% |
Profit Margin | -272.73% |
EBITDA Margin | -271.09% |
EBIT Margin | -272.69% |
FCF Margin | n/a |
Dividends & Yields
Vitasora Health does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -37.16% |
Shareholder Yield | n/a |
Earnings Yield | -21.00% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on July 31, 2012. It was a reverse split with a ratio of 0.05.
Last Split Date | Jul 31, 2012 |
Split Type | Reverse |
Split Ratio | 0.05 |
Scores
Vitasora Health has an Altman Z-Score of -1.8 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -1.8 |
Piotroski F-Score | 3 |